HOME › Press Releases › Biomaterials Market Worth 130.57 Billion USD by 2020
Biomaterials Market Worth 130.57 Billion USD by 2020
The report “Biomaterials Market by Type of Material (Metallic, Ceramic, Polymers, Natural Biomaterials) & Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurology, Tissue Engineering, Ophthalmology) - Global Forecast to 2020”, analyzes and studies the major market drivers, restraints/challenges, and opportunities.
Browse 179 market data tables and 64 figures spread through 297 pages and in-depth TOC on "Biomaterials Market by Type of Material (Metallic, Ceramic, Polymers, Natural Biomaterials) & Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurology, Tissue Engineering, Ophthalmology) - Global Forecast to 2020”
Early buyers will receive 10% customization on this report.
This report studies the global biomaterials market for the forecast period of 2015 to 2020. This market is expected to reach USD 130.57 Billion by 2020 from USD 62.06 Billion in 2015, at a CAGR of 16%.
The global biomaterials market is segmented on the basis of types of material, applications, and regions.
Based on the types of material, the biomaterials market is categorized into metallic, ceramic, polymers, and natural biomaterials. The metallic segment is further segmented into stainless steel, titanium & titanium alloys, cobalt-chrome alloys, silver, gold, and platinum. The ceramic segment is further segmented into aluminum oxide, zirconia, calcium phosphate, calcium sulphate, carbon, and glass. The polymers segment is further segmented into polymethylmethacrylate (PMMA), polyethylene, polyester, polyvinyl chloride, silicone rubber, nylon, and polyetheretherketone (PEEK). The natural biomaterials market is further segmented into hyaluronic acid, collagen & gelatin, fibrin, cellulose, chitin, alginate, and silk. In 2015, metallic segment is estimated for the larger share of the biomaterials market.
Based on application, the market is segmented into cardiovascular, orthopedic, dental, plastic surgery, wound healing, tissue engineering, ophthalmology, neurological /central nervous systems, and other applications which include drug delivery systems, gastrointestinal, bariatric surgery, and urinary applications. The cardiovascular segment is expected to account for the largest share of the biomaterials market in 2015. Orthopedic segment is expected to be the second-largest application area in 2015.
On the basis of regions, the global market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (Latin America, Middle East, and Africa). In 2015, North America is poised to account for the largest share of the biomaterials market, followed by Europe and Asia-Pacific. However, the Asia-Pacific market is slated to grow at the highest CAGR during the forecast period and serve as a revenue pocket for companies offering biomaterials.
A number of factors such as increased funds & grants by government bodies worldwide, growing implantable devices market, technological advancements, rising number of hip and knee replacement procedures, and high growth in geriatric population coupled with growing incidence of cardiovascular diseases are driving the growth of this market. In addition, high growth is expected for plastic surgery and wound healing applications, which will further drive the growth of the biomaterials market.
Prominent players in the global biomaterials market include Royal DSM (Netherlands), Wright Medical Technology, Inc. (U.S.), Corbion N.V. (Netherlands), Zimmer Biomet Holdings, Inc. (U.S.), Bayer AG (Germany), Carpenter Technology Corporation (U.S.), Covalon Technologies Ltd. (Canada), Evonik Industries AG (Germany), BASF SE (Germany), Invibio Ltd. (U.K.), Berkeley Advanced Biomaterials, Inc. (U.S.), CAM Bioceramics BV (Netherlands), and Collagen Matrix, Inc. (U.S.).
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India